Anti-aging Drugs
eBook - ePub

Anti-aging Drugs

From Basic Research to Clinical Practice

Alexander M Vaiserman, Alexander M Vaiserman

Buch teilen
  1. 570 Seiten
  2. English
  3. ePUB (handyfreundlich)
  4. Über iOS und Android verfügbar
eBook - ePub

Anti-aging Drugs

From Basic Research to Clinical Practice

Alexander M Vaiserman, Alexander M Vaiserman

Angaben zum Buch
Buchvorschau
Inhaltsverzeichnis
Quellenangaben

Über dieses Buch

Aging is a natural phenomenon that is peculiar to all living things. However, accumulating findings indicate that senescence could be postponed or prevented by certain approaches. Substantial evidence has emerged supporting the possibility of radical human health and lifespan extension, in particular through pharmacological modulation of aging. A number of natural dietary ingredients and synthetic drugs have been assumed to have geroprotective potential. In the development of anti-aging therapeutics, several cell, insect, and animal models may provide useful starting points prior to human studies.
This book provides an overview of current research aimed to search for life-extendingmedications and describes pharmacological aspects of anti-aging medicine. Readers are introduced to the fascinating historical background of geroprotection in the first chapter. In-depth information on models for investigating geroprotective drugs precedes a section covering anti-aging properties of pharmaceutical compounds, such as calorie restriction mimetics, autophagy inducers, senolytics and mitochondrial antioxidants. Finally, strategies to translate discoveries from aging research into drugs and healthcare policy perspectives on anti-ageing medicine are provided to give a complete picture of the field.
A timely and carefully edited collection of chapters by leading researchers in the field, this book will be a fascinating and useful resource for pharmacologists, gerontologists and any scientifically interested person wishing to know more about the current status of research into anti-aging remedies, challenges and opportunities.

Häufig gestellte Fragen

Wie kann ich mein Abo kündigen?
Gehe einfach zum Kontobereich in den Einstellungen und klicke auf „Abo kündigen“ – ganz einfach. Nachdem du gekündigt hast, bleibt deine Mitgliedschaft für den verbleibenden Abozeitraum, den du bereits bezahlt hast, aktiv. Mehr Informationen hier.
(Wie) Kann ich Bücher herunterladen?
Derzeit stehen all unsere auf Mobilgeräte reagierenden ePub-Bücher zum Download über die App zur Verfügung. Die meisten unserer PDFs stehen ebenfalls zum Download bereit; wir arbeiten daran, auch die übrigen PDFs zum Download anzubieten, bei denen dies aktuell noch nicht möglich ist. Weitere Informationen hier.
Welcher Unterschied besteht bei den Preisen zwischen den Aboplänen?
Mit beiden Aboplänen erhältst du vollen Zugang zur Bibliothek und allen Funktionen von Perlego. Die einzigen Unterschiede bestehen im Preis und dem Abozeitraum: Mit dem Jahresabo sparst du auf 12 Monate gerechnet im Vergleich zum Monatsabo rund 30 %.
Was ist Perlego?
Wir sind ein Online-Abodienst für Lehrbücher, bei dem du für weniger als den Preis eines einzelnen Buches pro Monat Zugang zu einer ganzen Online-Bibliothek erhältst. Mit über 1 Million Büchern zu über 1.000 verschiedenen Themen haben wir bestimmt alles, was du brauchst! Weitere Informationen hier.
Unterstützt Perlego Text-zu-Sprache?
Achte auf das Symbol zum Vorlesen in deinem nächsten Buch, um zu sehen, ob du es dir auch anhören kannst. Bei diesem Tool wird dir Text laut vorgelesen, wobei der Text beim Vorlesen auch grafisch hervorgehoben wird. Du kannst das Vorlesen jederzeit anhalten, beschleunigen und verlangsamen. Weitere Informationen hier.
Ist Anti-aging Drugs als Online-PDF/ePub verfügbar?
Ja, du hast Zugang zu Anti-aging Drugs von Alexander M Vaiserman, Alexander M Vaiserman im PDF- und/oder ePub-Format sowie zu anderen beliebten Büchern aus Medicine & Pharmacology. Aus unserem Katalog stehen dir über 1 Million Bücher zur Verfügung.

Information

Jahr
2017
ISBN
9781782629856
Auflage
1

Section IV

Mimicking Caloric Restriction

CHAPTER 10
Mimetics of Caloric Restriction
OLEH LUSHCHAKa* AND DMYTRO GOSPODARYOVa
a Department of Biochemistry and Biotechnology, Vasyl Stefanyk Precarpathian National University, 57 Shevchenko Str., Ivano-Frankivsk, 76018, Ukraine

10.1Introduction

Caloric restriction or calorie restriction (CR) is a relatively old concept, initially based on the data of McCay and colleagues.1 It was found that dietary-restricted rats lived longer than the corresponding controls.1 It was generally accepted for a long time that total amount of calories in consumed food did influence the life span of tested animals.2,3 After a while, life span extension by CR was observed for many model organisms, including fruit flies and nematodes.3 However, it was difficult to draw a distinct line between malnutrition and life span-prolonging CR. The mechanism of life span extension by limitation of ingested food was obscure. Hence, it is not distinguished whether food restriction improves some health parameters or overeating worsens them. In other words, an optimal caloric state was not set. On the one hand, a calorically restricted diet can be optimal for an organism while increasing the amount of food will worsen health and shorten life span.2,4 On the other hand, a “zero” point for amount of food consumed can be located between a supposedly “calorically restricted” diet and a diet promoting over-nutrition. It was found in the 2000s (Figure 10.1) that not only calories but particular nutrients, namely proteins, may play a role in determining life span.3,59 So, isocaloric diets with different amounts of proteins may result in different life spans of model organisms.3,9 At nearly the same time, the life-prolonging effects of resveratrol, a low molecular phenolic compound, were discovered.10 It was first noticed that resveratrol mimics CR.11,12 The molecular mechanisms of resveratrol were found to be mediated by NAD+-dependent histone deacetylases, sirtuins.11,1315 Parallels between the life-extending effect and mimicking physiological and molecular signs of CR were found for many anti-aging drugs, including glitazones16 and rapamycin.17 Simultaneously, a number of compounds that block catabolism of macronutrients or even ingestion were found to provide life span prolongation.18 For instance, acarbose and 2-deoxyglucose, which block glycogen breakdown and glycolysis, respectively, are among these compounds.18 It is suggested that some CR mimetics are not only inhibitors of catabolism but are signaling molecules shamming energy and/or nutrient sensors of cells. Indeed, a way of blockage of nutrient delivery to cells may not matter. The result is always either a lack of energy in the form of adenosine triphosphate (ATP) or deficiency of some building blocks for synthesis of proteins, polysaccharides and lipids. The question about the superiority of energy over plastic material or vice versa is still unresolved. In addition, it is still not clear whether we should take into account the number of calories in the diet, or dietary composition, or macronutrient balance, or even certain dietary components, which when taken away from the diet would provide life span extension. In this review we will try to provide a comprehensive picture for development of the CR concept, the tissue-specific and intracellular consequences of CR, a description of drugs that mimic CR outcomes, and suggest a mechanism explaining why a decrease in either energy or specific nutrients may lead to an increased life expectancy in particular biological species.
image
Figure 10.1Development of CR concept and related findings. Data were obtained from Masoro.19 The figure is modified from Benjamin et al.20 Briefly, the first book on CR collected data on the effects of CR on organismal life span and was published in 1988. Until the mid-1990s, the life-prolonging effects of CR had been proven for main classes of the Animalia kingdom, including humans. Since the mid-1990s, several other concepts have been overlapping with the CR concept (e.g., the hypothesis of methionine restriction). The first compound that prolongs life span by mimicking CR, resveratrol, was discovered in 2003. In each box: in black font: surname(s) of the investigator(s); in blue font: either model organism tested, or experiment mode, or key finding.

10.2Aging and CR

The first evidence on the ability of CR to extend life span came from experiments performed in rats by McCay and colleagues.1 Further studies showed that CR extended the life span by shifting mortality factors, such as diseases and tumors, to older age. Using different protocols, researchers revealed the life span extension by CR in many organisms like yeast, rotifers, spiders, nematodes, flies, fishes and mammals, including non-human primates (Figure 10.1).

10.2.1CR in Yeast: Saccharomyces cerevisiae

Replicative and chronological life spans are described for unicellular yeast. The replicative life span is measured by the amount of formed daughter cells produced by a single cell. Reduction of the glucose concentration from 2% to 0.5% was the first CR intervention in yeast and this extended the replicative life span two-fold. The same study showed the importance of certain genes (SIR2, FOB1, CYT1) for mediating this phenotype. In addition, gene expression profiles of mutants with overexpression of HXK2 and HAP4 showed significant overlap with CR-treated cells. A similar protocol was used in later studies to show the importance of the TOR pathway and transcription factors Msn2 and Msn4 in mediating life span extension by CR. In addition, many genes and factors were identified in yeast as important regulators of life span. The life-extending properties of many drugs, remedies and natural extracts were later discovered using this method.2123
Chronological life span is also described for unicellular organisms such as yeast Saccharomyces cerevisiae. Determination of chronological life span requires a measurement of the number of alive cells able to produce colonies while transferred to fresh media over different time points.24 Cells are quiescent in the G0 phase of the cell cycle but are metabolically active thus having some similarities to those of postmitotic tissues in adult multicellular organisms. Taking into account the similarities of basic biochemical pathways in yeast and other organisms, the model of yeast replicative and chronological life spans can be success...

Inhaltsverzeichnis